Ntm Lung Disease
Metals, sulfate in water heighten risk for mycobacterial infections in cystic fibrosis
Among patients with cystic fibrosis, increases in sulfate and specific metals in water raised the odds for nontuberculosis mycobacterial infections, according to results published in Environmental Epidemiology.
Arikayce shows promise among patients newly diagnosed with NTM lung disease
A drug that treats nontuberculous mycobacterial lung infections caused by Mycobacterium avium complex performed well among newly diagnosed patients who had not started antibiotics, its manufacturer said.
Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Supported by an educational grant from Insmed.
Halting the Vicious Vortex: Case-based Discussions in Non-Cystic Fibrosis Bronchiectasis
Supported by an educational grant from Insmed.
Immunotherapy in NMSC: Challenges in CSCC and BCC
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Save Their Breath: Diagnosing and Treating NTM-LD
This activity is supported by an educational grant from Insmed.
Immunotherapy in NMSC: Bringing the Data to Life
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Breath-Taking Stories: A Discussion of Real-World Cases of NTM-LD
This activity is supported by an educational grant from Insmed.